Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;83:738-742

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rebolledo, M. A.
Right arrow Articles by Klitzner, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rebolledo, M. A.
Right arrow Articles by Klitzner, T. S.
(Circulation Research. 1998;83:738-742.)
© 1998 American Heart Association, Inc.


Original Contributions

Infection of Human Fetal Cardiac Myocytes by a Human Immunodeficiency Virus-1–Derived Vector

Michael A. Rebolledo, Paul Krogstad, Fuhua Chen, Kevin M. Shannon, , Thomas S. Klitzner

From the Department of Pediatrics, University of California Los Angeles School of Medicine, Los Angeles, Calif.

Correspondence to Michael A. Rebolledo, MD, UCLA Medical Center, Department of Pediatrics, Division of Cardiology, Box 951743, Room B2-427 MDCC, Los Angeles, CA 90095-1743. E-mail mrebolle{at}ucla.edu

Abstract—Cardiomyopathy associated with HIV-1 infection is a well-recognized complication. However, it is unknown whether direct cardiomyocyte infection is involved in the pathogenesis of the cardiomyopathy. An HIV-1–based lentiviral vector and wild-type HIV-1 were used to infect human fetal cardiac myocytes in a primary culture. Quantitative polymerase chain reaction, viral p24 antigen determination, and immunofluorescence were used to detect the synthesis of HIV-1 DNA and proteins after the infection. High-efficiency infection occurred using the HIV-1–based lentiviral vector, although no infection occurred with the wild-type HIV-1 strain. Dual-labeling immunofluorescence for HIV-1 proteins and myosin confirmed that cardiomyocytes were infected. This in vitro analysis suggests that direct myocyte infection with wild-type HIV-1 may not be involved in the pathogenesis of HIV-1 cardiomyopathy. However, HIV-1–based vectors may prove useful for ex vivo cardiovascular gene therapy.


Key Words: fetal heart • gene therapy • cardiomyopathy • human immunodeficiency virus • cell culture




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
C. Ricci, V. Pastukh, J. Leonard, J. Turrens, G. Wilson, D. Schaffer, and S. W. Schaffer
Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis
Am J Physiol Cell Physiol, February 1, 2008; 294(2): C413 - C422.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Fleury, E. Simeoni, C. Zuppinger, N. Deglon, L. K. von Segesser, L. Kappenberger, and G. Vassalli
Multiply Attenuated, Self-Inactivating Lentiviral Vectors Efficiently Deliver and Express Genes for Extended Periods of Time in Adult Rat Cardiomyocytes In Vivo
Circulation, May 13, 2003; 107(18): 2375 - 2382.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. M. Feldman and D. McNamara
Myocarditis
N. Engl. J. Med., November 9, 2000; 343(19): 1388 - 1398.
[Full Text] [PDF]


Home page
CirculationHome page
R. P. Shannon, M. A. Simon, M. A. Mathier, Y.-J. Geng, S. Mankad, and A. A. Lackner
Dilated Cardiomyopathy Associated With Simian AIDS in Nonhuman Primates
Circulation, January 18, 2000; 101(2): 185 - 193.
[Abstract] [Full Text] [PDF]